These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 15004731

  • 1. Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.
    Fahlbusch SA, Tsikas D, Mehls C, Gutzki FM, Böger RH, Frölich JC, Stichtenoth DO.
    Eur J Clin Pharmacol; 2004 Apr; 60(2):83-8. PubMed ID: 15004731
    [Abstract] [Full Text] [Related]

  • 2. A comparison of carvedilol and metoprolol antioxidant activities in vitro.
    Lysko PG, Webb CL, Gu JL, Ohlstein EH, Ruffolo RR, Yue TL.
    J Cardiovasc Pharmacol; 2000 Aug; 36(2):277-81. PubMed ID: 10942172
    [Abstract] [Full Text] [Related]

  • 3. Carvedilol treatment ameliorates acute coxsackievirus B3-induced myocarditis associated with oxidative stress reduction.
    Li YC, Ge LS, Yang PL, Tang JF, Lin JF, Chen P, Guan XQ.
    Eur J Pharmacol; 2010 Aug 25; 640(1-3):112-6. PubMed ID: 20457150
    [Abstract] [Full Text] [Related]

  • 4. Isoprostanes inhibit vascular endothelial growth factor-induced endothelial cell migration, tube formation, and cardiac vessel sprouting in vitro, as well as angiogenesis in vivo via activation of the thromboxane A(2) receptor: a potential link between oxidative stress and impaired angiogenesis.
    Benndorf RA, Schwedhelm E, Gnann A, Taheri R, Kom G, Didié M, Steenpass A, Ergün S, Böger RH.
    Circ Res; 2008 Oct 24; 103(9):1037-46. PubMed ID: 18802021
    [Abstract] [Full Text] [Related]

  • 5. Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
    Liang Y, Wei P, Duke RW, Reaven PD, Harman SM, Cutler RG, Heward CB.
    Free Radic Biol Med; 2003 Feb 15; 34(4):409-18. PubMed ID: 12566066
    [Abstract] [Full Text] [Related]

  • 6. Cardioprotective effects of carvedilol on acute autoimmune myocarditis: anti-inflammatory effects associated with antioxidant property.
    Yuan Z, Shioji K, Kihara Y, Takenaka H, Onozawa Y, Kishimoto C.
    Am J Physiol Heart Circ Physiol; 2004 Jan 15; 286(1):H83-90. PubMed ID: 14684360
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation.
    Yue TL, Wang X, Gu JL, Ruffolo RR, Feuerstein GZ.
    Eur J Pharmacol; 1995 Dec 29; 294(2-3):585-91. PubMed ID: 8750722
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 8-iso-prostaglandin F(2alpha) increases expression of LOX-1 in JAR cells.
    Halvorsen B, Staff AC, Henriksen T, Sawamura T, Ranheim T.
    Hypertension; 2001 Apr 29; 37(4):1184-90. PubMed ID: 11304522
    [Abstract] [Full Text] [Related]

  • 17. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.
    De Caterina R, Cipollone F, Filardo FP, Zimarino M, Bernini W, Lazzerini G, Bucciarelli T, Falco A, Marchesani P, Muraro R, Mezzetti A, Ciabattoni G.
    Circulation; 2002 Nov 12; 106(20):2543-9. PubMed ID: 12427649
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Randomized, double-blind comparison of acute beta1-blockade with 50 mg metoprolol tartrate vs 25 mg carvedilol in normal subjects.
    Billeh R, Hirsh D, Barker C, Jorgensen B, Jeger R, Ramanathan K, Tseng CH, Hudaihed A, Haas F, Jorde UP.
    Congest Heart Fail; 2006 Nov 12; 12(5):254-7. PubMed ID: 17033273
    [Abstract] [Full Text] [Related]

  • 20. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM.
    Pharmacotherapy; 2009 Aug 12; 29(8):883-90. PubMed ID: 19637941
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.